Nuo Therapeutics Inc (AURX) stock news · rev $3.1M
Nuo Therapeutics Inc (AURX) is a biotechnology company listed on US.
This AURX news page leads with what Nuo Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for AURX yet. We will not pad this page with generic market recap.
Latest reported AURX revenue for 2026-06-30 was $3.1M. Net income was -$896.1K. AURX currently screens at market cap $72.1M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the AURX stock page; for the tape open the quote page.
Not investment advice.